Select Your Region
Americas
Europe
Africa
Global
Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- coBRIM
A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma
Cancer Skin Cancer Malignant Melanoma
Study results
LPS_GO28141_coBRIM_final results_June2021_English
(PDF, 1.9 MB)
LPS_GO28141_coBRIM_final results_June2021_Czech
(PDF, 0.3 MB)
LPS_GO28141_coBRIM_final results_June2021_French_Canada
(PDF, 0.4 MB)
LPS_GO28141_coBRIM_final results_June2021_French_France
(PDF, 0.4 MB)
LPS_GO28141_coBRIM_final results_June2021_German
(PDF, 0.4 MB)
LPS_GO28141_coBRIM_final results_June2021_Hebrew
(PDF, 0.3 MB)
LPS_GO28141_coBRIM_final results_June2021_Hungarian
(PDF, 0.4 MB)
LPS_GO28141_coBRIM_final results_June2021_Italian
(PDF, 0.4 MB)
LPS_GO28141_coBRIM_final results_June2021_Dutch_Netherland
(PDF, 0.3 MB)
LPS_GO28141_coBRIM_final results_June2021_Norwegian
(PDF, 0.3 MB)
LPS_GO28141_coBRIM_final results_June2021_Russian
(PDF, 0.4 MB)
LPS_GO28141_coBRIM_final results_June2021_Spanish_Spain
(PDF, 0.4 MB)
LPS_GO28141_coBRIM_final results_June2021_Swedish
(PDF, 0.3 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com